ReviewCellular and molecular neurobiology2016
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.
Chelsea C Hays et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
120 papers cite itlatest 60 shown
this paperpooled ittrialcites it